ASX Compliance Update

Changes to ASX Listing Applications In a bid to enhance efficiency and clarity in the listing application process, the Australian Securities Exchange (ASX) has introduced several changes to its admission procedures, effective February 5, 2024. These changes set out in Compliance Update (no. 01/24) aim to simplify documentation requirements and improve compliance with spread and escrow […]

M&A Report: 2023 Year in Review and Future Outlook

In Mergermarket’s 2023 Global & Regional M&A Rankings, Hamilton Locke ranked 6th in Australia for the highest volume of M&A deals, with 69 deals valued at USD738 million. This is the firm’s highest Mergermarket ranking and a significant jump from 13th place in 2022. As part of our ongoing commitment to driving excellence in the […]

Hamilton Locke Advises EMVision on $15.28M Strategic Placement with Keysight Technologies

Hamilton Locke is pleased to have advised EMVision Medical Devices Limited (ASX: EMV) on its $15.28 million strategic placement with Keysight Technologies Inc (NYSE: KEYS). The deal represents a significant milestone for EMVision, positioning the company for accelerated growth, market penetration, and continued innovation in medical imaging technology. The investment will facilitate and fund EMVision’s […]

Hamilton Locke Assists on Successful Restructure of the Body Catalyst Group

Hamilton Locke recently advised Alan Walker and Glenn Livingstone of WLP Restructuring in their capacity as voluntary administrators of the Body Catalyst Group on the successful restructure of its body shaping and wellness treatment business. On 7 December 2023, 46 companies in the Body Catalyst Group, a non-invasive body sculpting cosmetic chain with clinics around […]

Alistair Newton

As a competition and consumer specialist, Alistair has a deep understanding of the market contexts in which his clients operate. He is driven by the challenge of navigating complex legal and economic problems to achieve the best commercial and regulatory outcomes. Alistair prides himself on his reliability, diligence and acumen. Alistair has over 15 years’ […]

Unfair Contract Terms Regime: What are the New Penalties for Australian Businesses?

Late 2023 saw the significant expansion of Australia’s ‘unfair contract terms’ (UCT) regime, as the changes to the competition provisions of the Competition and Consumer Act 2010 (Cth) commenced. These changes are particularly relevant to businesses in industries where it is common practice to provide products or services on standard terms, such as suppliers of […]

Hamilton Locke Advises the University of Newcastle, UTS, Macquarie University and WSU on Joining Uniseed Venture Fund

Hamilton Locke advised a consortium of NSW universities (comprising of, the University of Newcastle, University of Technology Sydney, Macquire University and Western Sydney University) on joining the Uniseed venture fund in order to invest in the future of Australian innovation. This deal presents a significant expansion of research partners for Uniseed. The four NSW universities […]

Hamilton Locke Advises on the Acquisition of 24-7 Healthcare from Crescent and Associated Investment and Financing Arrangements

Hamilton Locke has advised MA Growth Ventures on an A$20m growth capital investment into the DoctorSquare group. We then advised DoctorSquare on the acquisition of the 24-7 Healthcare Group from Crescent Capital Partners. Commonwealth Bank Australia’s CommBank Health division provided financing for the acquisition. Led by experienced GPs, Dr James Liang, and Dr Jonathan Brown, […]

Hamilton Locke Acts for Australian Business Growth Fund on their investment in Inskin Cosmedics

Hamilton Locke is delighted to have acted for Australian Business Growth Fund (ABGF) on their investment in INSKIN COSMEDICS. ABGF is Australia’s only purpose built growth capital fund dedicated to investing in Australian SMEs. INSKIN is Australia’s largest vertically integrated professional skincare company. INSKIN manufactures, distributes and retails its own brand of specialist ‘cosmedical’ skincare […]

Corin Maberly

With over 25 years of legal experience, Corin has a reputation for excellent legal and business judgment, operating as an integral part of the client’s team, and working in a pragmatic way to help his clients achieve their business objectives. Corin is passionate about challenging the status quo of the legal market in New Zealand […]